TrialRMD open2024

Long-term clinical outcomes of certolizumab pegol treatment in non-radiographic axial spondyloarthritis stratified by baseline MRI and CRP status.

Martin Rudwaleit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.